Healthcare provider profile · identity verified

Sandra Boucher Mcgrath, APRN

Nurse Practitioner · BURLINGTON, VT · NPI 1346271046

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	446	47
Famotidine	Famotidine	346	28
Levothyroxine Sodium	Levothyroxine Sodium	335	28
Simvastatin	Simvastatin	258	12
Metoprolol Tartrate	Metoprolol Tartrate	247	13
Gabapentin	Gabapentin	228	28
Pantoprazole Sodium	Pantoprazole Sodium	226	33
Furosemide	Furosemide	207	23
Eliquis	Apixaban	203	31
Lisinopril	Lisinopril	203	18
Mirtazapine	Mirtazapine	162	17
Trazodone Hcl	Trazodone Hcl	159	18
Metoprolol Succinate	Metoprolol Succinate	146	21
Escitalopram Oxalate	Escitalopram Oxalate	142	suppressed
Bupropion Xl	Bupropion Hcl	134	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	126	suppressed
Torsemide	Torsemide	123	16
Sertraline Hcl	Sertraline Hcl	115	14
Amlodipine Besylate	Amlodipine Besylate	109	16
Glimepiride	Glimepiride	105	suppressed
Olanzapine	Olanzapine	104	suppressed
Risperidone	Risperidone	103	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	97	13
Finasteride	Finasteride	96	suppressed
Lorazepam	Lorazepam	94	28
Citalopram Hbr	Citalopram Hydrobromide	88	suppressed
Metformin Hcl	Metformin Hcl	87	suppressed
Sucralfate	Sucralfate	86	suppressed
Tramadol Hcl	Tramadol Hcl	84	27
Baclofen	Baclofen	83	suppressed
Midodrine Hcl	Midodrine Hcl	83	suppressed
Donepezil Hcl	Donepezil Hcl	80	suppressed
Carvedilol	Carvedilol	78	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	76	11
Oxycodone Hcl	Oxycodone Hcl	73	24
Venlafaxine Hcl Er	Venlafaxine Hcl	71	suppressed
Allopurinol	Allopurinol	66	suppressed
Spironolactone	Spironolactone	65	suppressed
Metformin Hcl Er	Metformin Hcl	63	suppressed
Divalproex Sodium	Divalproex Sodium	61	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	59	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	57	21
Benztropine Mesylate	Benztropine Mesylate	52	suppressed
Digoxin	Digoxin	52	suppressed
Clonazepam	Clonazepam	51	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	12
Losartan Potassium	Losartan Potassium	45	suppressed
Tizanidine Hcl	Tizanidine Hcl	45	suppressed
Austedo	Deutetrabenazine	43	suppressed
Omeprazole	Omeprazole	43	11
Primidone	Primidone	43	suppressed
Dexlansoprazole Dr	Dexlansoprazole	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Divalproex Sodium Er	Divalproex Sodium	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Cephalexin	Cephalexin	32	14
Prednisone	Prednisone	32	11
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	14
Methocarbamol	Methocarbamol	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	28	14
Hydromorphone Hcl	Hydromorphone Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Morphine Sulfate	Morphine Sulfate	26	13
Xarelto	Rivaroxaban	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	14
Gemtesa	Vibegron	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Colchicine	Colchicine	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	23	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Meloxicam	Meloxicam	21	suppressed
Nystatin	Nystatin	21	16
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Albuterol Sulfate	Albuterol Sulfate	19	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	18
Albuterol Sulfate Hfa	Albuterol Sulfate	18	14
Aripiprazole	Aripiprazole	18	suppressed
Atenolol	Atenolol	18	suppressed
Haloperidol	Haloperidol	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Bupropion Hcl	Bupropion Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Levocarnitine	Levocarnitine	13	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Belsomra	Suvorexant	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ozempic	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error